Fresh & Ready Foods has voluntarily recalled products with “use by” dates from April 22 to May 19, 2025, CNN said. The items were sold under the brand names Fresh & Ready Foods, City Point Market ...

Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery use among adolescents increased.

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right-sided lesion dissection.

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.